Scopus BioPharma Inc. (SCPS)
0.00
-0.00 (-100.00%)
At close: Feb 28, 2025, 3:00 PM
Scopus BioPharma Balance Sheet Statement
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 124.58K | 7.94M | 1.83M | 36.75K | 1.66K | 158.22K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a |
| Receivables | n/a | n/a | n/a | 562.00 | 27.86K | 54.65K |
| Inventory | n/a | n/a | n/a | 730.71K | n/a | n/a |
| Other Current Assets | 265.43K | 241.9K | 139.64K | 730.71K | 103.12K | n/a |
| Total Current Assets | 390K | 8.18M | 1.97M | 768.02K | 132.64K | 212.87K |
| Property-Plant & Equipment | 2.27K | 2.84K | 2.33K | 3.66K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 2.27K | 2.84K | 2.33K | 3.66K | n/a | n/a |
| Total Assets | 392.26K | 8.19M | 1.97M | 771.68K | 132.64K | 212.87K |
| Account Payables | n/a | n/a | n/a | n/a | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | 2.28M | n/a | n/a | n/a |
| Other Current Liabilities | 7.45M | 4.17M | 1.52M | 854.54K | 137.96K | 111.28K |
| Total Current Liabilities | 7.45M | 4.17M | 3.81M | 854.54K | 137.96K | 111.28K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 7.45M | 4.17M | 3.81M | 854.54K | 137.96K | 111.28K |
| Total Debt | n/a | n/a | 2.28M | n/a | n/a | n/a |
| Common Stock | 21.09K | 21.09K | 14.58K | 12.51K | 10.77K | 10.36K |
| Retained Earnings | -53.06M | -41.46M | -14.5M | -3.64M | -949.5K | -263.53K |
| Comprehensive Income | -4.95K | -86.65K | -68.07K | -33.45K | -9.56K | n/a |
| Shareholders Equity | -6.56M | 4.02M | -1.83M | -82.86K | -5.33K | 101.59K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |